Under the agreement, Think Surgical will have exclusive distribution rights to Curexo’s Cuvis-Joint robotic platform, according to an Aug. 1 news release. The companies have a history distributing Think Surgical’s TSolution One platform in Korea and Vietnam.
The Cuvis-Joint robot is used in Korea and India, with more than 4,000 cases done with the device. Think Surgical will be responsible for getting Cuvis-Joint FDA-cleared in the U.S.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
